Jean-Luc Vandebroek has joined Bone Therapeutics SA as chief financial officer to help develop a commercial strategy for the company’s clinical-stage portfolio of cell therapies for bone diseases. Mr Vandebroek previously worked for the Alcopa Group in Belgium, and as well as for the retailer Ahold Delhaize. He replaces Wim Goemaere, who is leaving the company to join the charitable sector.
Bone Therapeutics announced the appointment on 31 August 2017.
Copyright 2017 Evernow Publishing Ltd